Publications by authors named "Gavin M Marx"

Claim this Profile
A
A protocol for pre-treatment testing for antibodies to galactose-alpha-1,3-galactose to mitigate the risk of cetuximab hypersensitivity reactions - a retrospective cohort review.
Nicholas Della Marta, Alexander Yuile, Claire Mok, Joe Wei, Meredith Oatley, Gavin M Marx

Cancer Treat Res Commun· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enzalutamide with standard first-line therapy for metastatic hormone-sensitive prostate cancer: a plain language summary of the ENZAMET trial (ANZUP 1304).
Ciara Conduit, Andrisha-Jade Inderjeeth, Raymond Allen, Andrew J Martin, Wendy Parulekar, Gavin M Marx

Future Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physical activity behaviors in cancer survivors treated with neurotoxic chemotherapy.
David Mizrahi, David Goldstein, Terry Trinh, Tiffany Li, Hannah C Timmins, Gavin M Marx

Asia Pac J Clin Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP.
Martin R Stockler, Andrew J Martin, Ian D Davis, Haryana M Dhillon, Stephen D Begbie, Gavin M Marx

J Clin Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall Survival of Men with Metachronous Metastatic Hormone-sensitive Prostate Cancer Treated with Enzalutamide and Androgen Deprivation Therapy.
Christopher J Sweeney, Andrew J Martin, Martin R Stockler, Stephen Begbie, Kim N Chi, Gavin M Marx

Eur Urol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlating Ki67 and other prognostic markers with Oncotype DX recurrence score in early estrogen receptor-positive breast cancer.
Aaron C Tan, Bob T Li, Kazi Nahar, Suzanne Danieletto, Eva S Fong, Gavin M Marx

Asia Pac J Clin Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cisplatin-induced syndrome of inappropriate antidiuretic hormone secretion (SIADH) with life-threatening hyponatraemia.
Aaron C Tan, Gavin M Marx

BMJ Case Rep· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: A meta-analysis of randomized trials.
Bob T Li, Tristan A Barnes, David L Chan, Jarushka Naidoo, Adrian Lee, Gavin M Marx

Lung Cancer· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geriatric assessment of older patients with cancer in Australia--a multicentre audit.
Roopa Lakhanpal, Jaclyn Yoong, Sachin Joshi, Desmond Yip, Linda Mileshkin, Gavin M Marx

J Geriatr Oncol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe symptomatic hypocalcaemia following a single dose of denosumab.
Jennifer M McLachlan, Gavin M Marx, Margaret Bridgman

Med J Aust· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of candidate biomarkers of therapeutic response to docetaxel by proteomic profiling.
Liangli Zhao, Brian Y Lee, David A Brown, Mark P Molloy, Gavin M Marx

Cancer Res· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined modality treatments in early non-small cell lung cancer.
Peter Harper, Gavin M Marx

Lung Cancer· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life: it's never too late.
Christopher B Steer, Gavin M Marx, Eleni Galani, Peter G Harper, David Khayat

J Clin Oncol· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unexpected serious toxicity with chemotherapy and antiangiogenic combinations: time to take stock!
Gavin M Marx, Christopher B Steer, Peter Harper, Nick Pavlakis, Olivier Rixe

J Clin Oncol· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis